EPM2A 抗体 (AA 1-331)
EPM2A
适用: 人
WB
宿主: 小鼠
Monoclonal
9H116
unconjugated
-
-
抗原
See all EPM2A 抗体
-
EPM2A
(Epilepsy, Progressive Myoclonus Type 2A, Lafora Disease (Laforin) (EPM2A))
-
抗原表位
-
AA 1-331
-
适用
-
人
-
宿主
-
小鼠
-
克隆类型
-
单克隆
-
标记
-
This EPM2A antibody is un-conjugated
-
应用范围
-
Western Blotting (WB)
-
交叉反应
-
人
-
交叉反应 (详细)
-
Calculated cross reactivity: Hu
-
产品特性
-
Epilepsy, Progressive Myoclonus Type 2A (Lafora Disease, EPM2A, Laforin, LD, LDE, EPM2, MELF, LAFPTPase, FLJ11207, KIAA0766)
-
纯化方法
-
Purified by Protein G immunoaffinity chromatography.
-
免疫原
-
Purified, E. coli-derived full length recombinant human Laforin (rhLaforin, aa 1-331, UniProt # O95278).
-
克隆位点
-
9H116
-
亚型
-
IgG2b
-
Top Product
-
Discover our top product EPM2A Primary Antibody
-
-
-
应用备注
-
Optimal working conditions should be determined by the investigator.
-
限制
-
仅限研究用
-
-
状态
-
Liquid
-
溶解方式
-
Reconstitute in PBS containing 0.02 % sodium azide.
-
缓冲液
-
Supplied as lyophilized from a 0.2um sterile-filtered solution in PBS with 5 % trehalose.
-
储存液
-
Sodium azide
-
注意事项
-
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
-
-20 °C
-
储存方法
-
-20°C
-
-
抗原
-
EPM2A
(Epilepsy, Progressive Myoclonus Type 2A, Lafora Disease (Laforin) (EPM2A))
-
别名
-
Epilepsy, Progressive Myoclonus Type 2A (EPM2A 产品)
-
别名
-
TG-B antibody, Tg(TcraK,TcrbK)TG-BFlv antibody, EPM2 antibody, MELF antibody, laforin antibody, EPM2A, laforin glucan phosphatase antibody, epilepsy, progressive myoclonic epilepsy, type 2 gene alpha antibody, EPM2A antibody, Epm2a antibody
-
UniProt
-
O95278
-
途径
-
Cellular Glucan Metabolic Process
-